INHIBITION OF THE 5-HT-INDUCED CARDIOGENIC HYPERTENSIVE CHEMOREFLEX BY THE SELECTIVE 5-HT3 RECEPTOR ANTAGONIST ICS 205-930

被引：0
|
作者：
BERTHOLD, H
SCHOLTYSIK, G
ENGEL, G
机构：
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1989年 / 339卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：259 / 262
页数：4
相关论文
共 50 条
  • [21] ANTIEMETIC ACTION OF 5-HT-3 RECEPTOR ANTAGONISTS - REVIEW OF PRECLINICAL AND CLINICAL-RESULTS WITH ICS 205-930
    GAMSE, R
    CANCER TREATMENT REVIEWS, 1990, 17 (2-3) : 301 - 305
  • [22] Evidence for 5-HT3 receptor involvement in the 5-HT-induced contraction in the mouse isolated ileum
    Tuladhar, BR
    Womack, MD
    Naylor, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 : U36 - U36
  • [23] ENHANCEMENT OF MEMORY RETRIEVAL AND ATTENUATION OF SCOPOLAMINE-INDUCED AMNESIA FOLLOWING ADMINISTRATION OF 5-HT3 ANTAGONIST ICS-205-930
    CHUGH, Y
    SAHA, N
    SANKARANARAYANAN, A
    DATTA, H
    PHARMACOLOGY & TOXICOLOGY, 1991, 69 (02): : 105 - 106
  • [24] THE 5-HT INDUCED BIPHASIC VASODILATATION IN THE HUMAN FOREARM IS DOSE-DEPENDENTLY ANTAGONIZED BY ICS 205-930
    BLAUW, GJ
    VANBRUMMELEN, P
    VANZWIETEN, PA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (05) : P663 - P664
  • [25] EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, ICS 205-930, ON ESOPHAGEAL MOTOR-ACTIVITY AND ON LOWER ESOPHAGEAL SPHINCTER PRESSURE - A DOUBLE-BLIND CROSS-OVER STUDY
    STACHER, G
    STEINER, G
    GAUPMANN, G
    STACHERJANOTTA, G
    SCHNEIDER, C
    STEINRINGER, H
    HEPATO-GASTROENTEROLOGY, 1990, 37 : 118 - 121
  • [26] THE ROLE OF 5-HT3 RECEPTOR-MEDIATED MECHANISMS ON 5-HT-INDUCED APNEA IN ANESTHETIZED RATS
    GODA, Y
    YOSHIOKA, M
    TOGASHI, H
    ABE, M
    SAITO, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (03) : 705 - 706
  • [27] THE EFFECTS OF ICS 205-930, A 5-HT ANTAGONIST, ON ARRHYTHMIAS AND CATECHOLAMINE RELEASE DURING CANINE MYOCARDIAL-ISCHEMIA AND REPERFUSION
    COKER, SJ
    DEAN, HG
    KANE, KA
    PARRATT, JR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 127 (03) : 211 - 218
  • [28] A COMPARATIVE-STUDY OF THE USE OF NAVOBAN (ICS 205-930), A 5-HT3 ANTAGONIST, VERSUS A STANDARD ANTIEMETIC REGIMEN OF DEXAMETHASONE AND METOCLOPRAMIDE IN THE TREATMENT OF CISPLATIN-CONTAINING CHEMOTHERAPY
    MADEJ, G
    KRZAKOWSKI, M
    PAWINSKI, A
    LASOTA, W
    ROGOWSKI, W
    SKONECZNA, I
    DRUG INVESTIGATION, 1993, 6 (03): : 162 - 169
  • [29] The inhibition of cholera toxin-induced 5-HT release by the 5-HT3 receptor antagonist, granisetron, in the rat
    Turvill, JL
    Connor, P
    Farthing, MJG
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) : 1031 - 1036
  • [30] CHARACTERIZATION OF 5-HT3 RECOGNITION SITES IN MEMBRANES OF NG 108-15 NEUROBLASTOMA-GLIOMA CELLS WITH [H-3] ICS 205-930
    NEIJT, HC
    KARPF, A
    SCHOEFFTER, P
    ENGEL, G
    HOYER, D
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 337 (05) : 493 - 499
12345